View of THE EFFECTS OF GLUCAGON-LIKE PEPTIDE-1 AGONIST THERAPY (SEMAGLUTIDE AND TIRZEPATIDE) ON METABOLIC AND HORMONAL PARAMETERS IN MEN WITH OBESITY AND INSULIN RESISTANCE

Return to Issue Details THE EFFECTS OF GLUCAGON-LIKE PEPTIDE-1 AGONIST THERAPY (SEMAGLUTIDE AND TIRZEPATIDE) ON METABOLIC AND HORMONAL PARAMETERS IN MEN WITH OBESITY AND INSULIN RESISTANCE Download Download PDF